Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-Dimensional MRI Spatial Heterogeneity Analysis for Predicting Key Genes and Prognosis of High-Grade Gliomas: A Multi-Center Study

NCT06002711 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.

NCT NCT06002711
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06002711 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-Dimensional MRI Spatial Heterogeneity Analysis for Predicting Key Genes and Prognosis of High-Grade Gliomas: A Multi-Center Study
Lead sponsor
RenJi Hospital
Phase
Observational
Overall status
Recruiting
Start date
September 1, 2023
Completion date
December 31, 2027
Enrollment
500 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

high-grade glioma